Leukoplakia and Erythroplakia (Oral Premalignant Lesions)
Clinical descriptors of oral white (leukoplakia) and red (erythroplakia) patches that cannot be scraped off — premalignant; biopsy any persistent lesion.
Also known as: leukoplakia, erythroplakia, oral premalignant lesion, oral potentially malignant disorder, OPMD
Overview
Leukoplakia is a white plaque of the oral mucosa that cannot be scraped off and cannot be classified clinically or pathologically as any other disease. Erythroplakia is a red, velvety mucosal patch that similarly cannot be otherwise classified. Both are clinical descriptors; the underlying histology may range from hyperkeratosis to dysplasia to invasive carcinoma.
Epidemiology
Leukoplakia: prevalence approximately 1-5% in adults; more common in middle-aged to older men. Malignant transformation rate is 1-5% over 5 years for homogeneous leukoplakia; substantially higher (up to 30%) for nonhomogeneous, proliferative verrucous, or dysplastic forms. Erythroplakia: much less common (about 0.02-0.1%) but with malignant transformation rates of 14-50%; greater than 90% of biopsies show severe dysplasia or carcinoma.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Leukoplakia and Erythroplakia (Oral Premalignant Lesions) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Candida infection (associated with nonhomogeneous lesions)
Immunosuppression
Pathophysiology
Field cancerization — chronic carcinogen exposure produces multiple foci of genetically altered mucosa. Leukoplakia represents hyperkeratosis with variable dysplasia; erythroplakia reflects mucosal atrophy that exposes the underlying capillaries, often with severe dysplasia or carcinoma in situ. The risk of malignant transformation increases with size, nonhomogeneous appearance, high-risk subsite, presence of dysplasia, and continued carcinogen exposure.
Clinical presentation
Symptoms
Often asymptomatic; lesions are discovered on routine dental or medical exam
Patients may notice a 'rough patch,' burning, or sensitivity to spicy foods
Bleeding or ulceration is a worrisome sign for transformation
Signs / physical exam
Leukoplakia: white plaque that cannot be removed with gauze; may be homogeneous (smooth, thin) or nonhomogeneous (nodular, verrucous, mixed red-white)
Erythroplakia: red, velvety, well-demarcated mucosal patch, often atrophic, usually on the floor of mouth, lateral tongue, soft palate, or retromolar trigone
Erythroleukoplakia: mixed red and white lesion; higher dysplasia/carcinoma risk than pure leukoplakia
Induration, ulceration, or rapid change suggests malignant transformation
Classic findings
Painless white plaque (leukoplakia) or red velvety patch (erythroplakia) in a smoker, located on the lateral tongue or floor of mouth, that cannot be scraped off and persists beyond 2-3 weeks.
Differential diagnosis
Frictional hyperkeratosis (e.g., linea alba) — Bilateral white line along occlusal plane in buccal mucosa; reproducible with cheek-biting habit; benign
Oral lichen planus — Bilateral lace-like white striae (Wickham), often erosive; chronic and symmetrical; biopsy if atypical
Pseudomembranous candidiasis (thrush) — White plaques that WIPE OFF leaving erythematous mucosa; responds to antifungals
Leukoedema — Generalized milky-white opalescent buccal mucosa that disappears with stretching; benign variant; common in dark-skinned individuals
White sponge nevus — Hereditary, present since childhood, generalized white folded mucosa; benign
Hairy leukoplakia (EBV) — Corrugated white plaque on lateral tongue in immunocompromised (HIV); does not wipe off; non-premalignant
Mucosal erythema from chronic inflammation — Diffuse and reactive; resolves with elimination of irritant
Diagnostic workup
Diagnostic criteria
Clinical descriptors confirmed by exclusion of other diagnoses. Definitive risk stratification is by histopathology: hyperkeratosis without dysplasia, mild/moderate/severe dysplasia, carcinoma in situ, or invasive SCC.
Labs
Generally none required at the initial visit
HIV testing if hairy leukoplakia or risk factors are present
Imaging
Incisional biopsy of any persistent leukoplakia or erythroplakia — gold standard; from the most suspicious area (induration, ulceration, red component)
Multiple biopsies for large or nonhomogeneous lesions
Adjuncts such as toluidine blue staining, autofluorescence (VELscope), or brush biopsy may help select biopsy site but DO NOT replace tissue diagnosis
Imaging (CT/MRI) only if invasive carcinoma is suspected or for staging
Diagnostic algorithm
Feature
Homogeneous leukoplakia
Nonhomogeneous leukoplakia
Erythroplakia
Color
White, uniform
White with red or nodular areas
Red, velvety
Surface
Flat, smooth, thin
Verrucous, nodular, mixed
Atrophic, well-demarcated
Wipes off
No
No
No
Dysplasia at biopsy
5-25%
20-50%
Greater than 80-90%
Malignant transformation
1-5% over 5 years
10-30% over 5 years
14-50% (highest)
Management
Risk factor control + biopsy + surveillance; excise if dysplasia
Biopsy + excise; surveillance
Biopsy + complete excision
Risk stratification of common oral potentially malignant disorders.
Treatment
First-line
Eliminate risk factors — complete tobacco cessation (including smokeless), alcohol reduction, removal of mechanical irritants (smoothing of sharp teeth, refit dentures), treatment of candida if present
Surgical excision of all erythroplakia and of any lesion with moderate or severe dysplasia or carcinoma in situ
Excision or close surveillance of homogeneous leukoplakia without dysplasia, depending on size, site, and patient risk factors
Second-line / adjunct
Carbon dioxide laser ablation or cryotherapy as alternatives to scalpel excision for accessible lesions
Photodynamic therapy in selected centers
Topical agents (retinoids, bleomycin) have been studied but are not standard of care
Lifelong clinical surveillance — every 3-6 months for moderate-risk lesions, every 6-12 months for low-risk lesions
Re-biopsy any clinical change (color, induration, ulceration, growth)
Complications
Malignant transformation to invasive squamous cell carcinoma
Recurrence after excision (up to 30%, higher for proliferative verrucous leukoplakia)
Functional impairment after extensive excision
Field cancerization with metachronous lesions and second primaries
PANCE pearls
Leukoplakia and erythroplakia are clinical diagnoses of EXCLUSION; rule out lichen planus, candidiasis, and other named entities.
Erythroplakia and erythroleukoplakia have a far higher dysplasia and cancer rate than homogeneous leukoplakia — biopsy and excise.
If a 'leukoplakia' wipes off, it is candidiasis until proven otherwise.
Proliferative verrucous leukoplakia is the most aggressive variant — multifocal, persistent, transformation rates approaching 70%.
Even after complete excision, lifelong surveillance is required because of field cancerization.
References
WHO — WHO Classification of Head and Neck Tumours, 4th/5th edition — Oral potentially malignant disorders
ADA — American Dental Association evidence-based clinical recommendations on the diagnosis of oral potentially malignant disorders (Lingen et al., JADA 2017)
NCCN — NCCN Clinical Practice Guidelines: Head and Neck Cancers — screening and premalignant lesions
Practice EENT questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.